Next 15 Group (NFG) H1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2026 earnings summary
2 Oct, 2025Executive summary
Decisive leadership in the first 100 days addressed legacy issues, simplified the portfolio from 22 to 12 businesses, and clarified strategic direction.
Resilient trading and margin discipline maintained despite macroeconomic pressures, with strong growth in Consumer, Retail, Government, and Digital Transformation offsetting technology sector weakness.
Financial strength preserved through reduced net debt, a strong balance sheet, and maintained dividend.
Portfolio simplification and integration of key businesses delivered immediate cost efficiencies.
Strong culture, talent retention, and engagement highlighted as key strengths.
Financial highlights
Net revenue down 3.6% year-over-year to £230.8m, impacted by currency and tech sector weakness.
Adjusted operating margin improved to 14.2% from 14.1% year-over-year.
Adjusted profit before tax at £30.9m; statutory PBT fell to £2.8m due to Mach49 write-downs.
Adjusted diluted EPS increased to 21.4p, driven by reduced minority interests and cash earn-out settlements.
Net debt reduced to £45.3m from £74.8m a year ago; leverage at 0.5x EBITDA.
Interim dividend maintained at 4.75p per share.
Outlook and guidance
H1 performance in line with projections; early H2 trading also as expected, with full-year results anticipated to meet market expectations.
Growth expected in Digital Transformation, Retail Media, and data-driven services, with continued focus on cost and margin discipline.
FY26 results anticipated to be in line with market expectations: Net Revenue (excl. Mach49 and disposals) £454m, adjusted operating profit £66.5m.
Early signs of recovery in technology clients, but no rapid reversal anticipated.
Latest events from Next 15 Group
- FY26 on track with strong segment growth; FY27 set for further revenue and profit gains.NFG
Q4 2025 TU28 Jan 2026 - Flat revenue, lower profit, tech and government weakness, but B2C and health growth.NFG
H1 202520 Jan 2026 - Revenue and profit declined, but net debt fell and AI investment is accelerating.NFG
H2 202523 Dec 2025